2020 Life science Value creation 
Jake Jorgovan
NOVEMBER 29, 2023
NGT BioPharma Consultants : A consultancy firm specializing in drug development and advanced technologies, offering comprehensive support from late discovery to life cycle management for both small molecules and biologics. Broad expertise in business and technical domains. Known for natural process improvement.
LaVoie Health Science Blog
JULY 1, 2020
Sharp gains and losses in share prices, together with significant changes in share ownership mean that few companies, particularly those in the life science sector, are immune from the potential disruptions of shareholder activism. In the spring of 2020, in the heat of the COVID-19 crisis, just such a scenario played out.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TIM Review
FEBRUARY 27, 2021
2017; OECD, 2020) have reflected on how the bioeconomy can meet digitalization as a catalysing process that results in a kind of “new industrial revolution”. 2020), which is important because it aims at eliminating waste and the continual use of resources by employing reuse, sharing, repair, and recycling. 2015; Udovita, 2020).
TIM Review
OCTOBER 30, 2020
The “business model” concept has indeed been utilized to comprehensively understand how companies do business and perform processes of value creation, capture, and delivery (Schneider & Spieth, 2013; Foss & Saebi, 2017). 2018; Si & Chen, 2020). . 2018; Si & Chen, 2020). . Additionally, Johnson et al.
LaVoie Health Science Blog
JULY 16, 2021
Interviews with our senior practice managers about issues of important to life science innovators. As investments into sustainable companies and funds have surged to new highs, how can biotech and life science companies best position themselves with this burgeoning group of investors. Enough said.
Tackle.io
SEPTEMBER 21, 2021
Other categories included business applications, education, financial services, retail, manufacturing or industrial, media and entertainment, storage, telecom, government, and healthcare and life sciences. . Respondents represented six annual recurring revenue (ARR) segments, from less than $1 million to more than $1 billion.
Tackle.io
OCTOBER 25, 2022
Other categories included business applications, education, financial services, retail, manufacturing or industrial, media and entertainment, storage, telecom, government, and healthcare and life sciences. Respondents represented six annual recurring revenue (ARR) segments, from less than $1 million to more than $1 billion.
Expert insights. Personalized for you.
130 
Let's personalize your content